Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05699226 · ClinicalTrials.gov registry record · NA
Amplitude Titration to Improve ECT Clinical Outcomes
A NA study of Depression and Cognitive Change, sponsored by University of New Mexi.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05699226 is a NA study of Depression and Cognitive Change that is actively recruiting participants, run by University of New Mexi. The registered enrollment target is 50 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05699226, a NA study of Depression and Cognitive Change, is actively recruiting participants, sponsored by University of New Mexi.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized controlled trial will compare hippocampal neuroplasticity, antidepressant, and cognitive outcomes between individualized amplitude and fixed 800 mA amplitude ECT in older depressed subjects (n = 25 per group, n = 50 total). Relative to fixed 800 mA ECT: H1: Individualized amplitude arm will have improved RUL antidepressant outcome (IDS-C30 response rates and reduced BT electrode placement switch at V2). H2: Individualized amplitude arm will have improved cognitive outcomes (DKEFS-Verbal Fluency
Conditions Studied
Interventions
- DEVICE Soterix Medical Incorporated 4x1 adapter
- DEVICE Traditional ECT device
Study Locations (1)
New Mexico
- University of New Mexico Health Science Center - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-09-14 |
| Est. Completion | 2028-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05699226
The ClinicalTrials.gov registry entry for NCT05699226 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (94% lower). The listed sponsor is University of New Mexi, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Soterix Medical Incorporated 4x1 adapter is the first listed.
NCT05699226 reports 1 study location spanning 1 distinct geographic area - top geographies include New Mexico.
Frequently Asked Questions
What is clinical trial NCT05699226 about?
NCT05699226 is a clinical study titled "Amplitude Titration to Improve ECT Clinical Outcomes". A randomized controlled trial will compare hippocampal neuroplasticity, antidepressant, and cognitive outcomes between individualized amplitude and fixed 800 mA amplitude ECT in older depressed subjects (n = 25 per group, n = 50 total). Relative to fixed 800 mA ECT: H1: Individualized amplitude arm...
What is the current status of trial NCT05699226?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-09-14. Estimated completion is 2028-01-01.
What conditions does trial NCT05699226 study?
This clinical trial studies the following conditions: Depression, Cognitive Change, ECT.
What interventions are being tested in trial NCT05699226?
The interventions under investigation include: Soterix Medical Incorporated 4x1 adapter (DEVICE), Traditional ECT device (DEVICE).
Who is sponsoring clinical trial NCT05699226?
This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05699226 being conducted?
This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.